It looks like you're using an Ad Blocker.
Please white-list or disable AboveTopSecret.com in your ad-blocking tool.
Thank you.
Some features of ATS will be disabled while you continue to use an ad-blocker.
originally posted by: TiredofControlFreaks
a reply to: auroraaus
4. Vegetables and meat are your best friends. Have as much as you like.
originally posted by: TiredofControlFreaks
a reply to: M4ngo
I don't disagree with you.
Please explain the average age of death in the 70s and 80s???????
Also what are you going to say to the people who can't afford hundreds of dollars a month for insulin costs as opposed to $4.00 for metformin???????
Plus the cost of the blood test strips at a dollar a piece???????
Which big pharma do you work for? Its clear your purpose of the OP was not to inform about environmental concerns but to get people off of metformin?
Dr. Jeffrey R. Garber reports that he does not have any relevant financial relationships with any commercial interests.
Dr. Alan J. Garber reports that he is a consultant for Novo Nordisk and Intarcia
Dr. W. Timothy Garvey reports that he is a consultant for AstraZeneca, Janssen, Eisai, Takeda, Novo Nordisk, Alexion, and Merck. He has also received research grants from Merck, Weight Watchers, Sanofi, Eisai, AstraZeneca, Lexicon, Pfizer, Novo Nordisk, and Elcelyx. Dr. Garvey is a shareholder in ISIS Pharmaceuticals, Novartis, Bristol Myers Squibb, Pfizer, Merck, and Eli Lilly.
Dr. Martin Julian Abrahamson reports that he is a consultant for Novo Nordisk, WebMD Health Services, and Health IQ.
Dr. Joshua I. Barzilay reports that he does not have any relevant financial relationships with any commercial interests.
Dr. Lawrence Blonde reports that he is a consultant for AstraZeneca, GlaxoSmithKline, Intarcia, Janssen Pharmaceuticals, Inc., Merck & Co., Inc., Novo Nordisk, and Sanofi. He is also a speaker for AstraZeneca, Janssen Pharmacueticals, Inc., Merck & Co., Inc., Novo Nordisk, and Sanofi. Dr. Blonde has received research grant support from AstraZeneca, Janssen Pharmaceuticals, Inc., Lexicon Pharmaceuticals, Inc., Merck & Co., Novo Nordisk, and Sanofi.
Dr. George Grunberger reports that he has received speaker honoraria from Eli Lilly, BI-Lilly, Novo Nordisk, Sanofi, Janssen, and AstraZeneca. He has received research funding from AstraZeneca, Eli Lilly, Lexicon, and Medtronic.
Dr. Zachary Bloomgarden reports that he is a consultant for AstraZeneca, Johnson & Johnson, Merck, Intarcia, and Novartis. He is also a speaker for Merck, AstraZeneca, and Johnson & Johnson. He is a stock shareholder for Allergan, Pfizer, Zimmer Biomet, and Novartis.
Dr. Yehuda Handelsman reports that he is a consultant for Amarin, Amgen, AstraZeneca, Boehringer Ingelheim (BI), Janssen, Eli Lilly, Eisai, Intarcia, Merck, Novo Nordisk, Sano , and Regeneron. He is a speaker for Amarin, Amgen, AstraZeneca, BI-Lilly, Janssen, Novo Nordisk, Sanofi, and Regeneron. Dr. Handelsman has also received grant support from Amgen, AstraZeneca, BI, Esperion, Grifols, Hamni, GlaxoSmithKline, Lexicon, Merck, Novo Nordisk, and Sanofi.
Dr. Michael A. Bush reports that he is an Advisory Board Consultant for Janssen and Eli Lilly. He is on the speaker’s bureau for Takeda, Eli Lilly, Novo Nordisk, AstraZeneca, and Boehringer Ingelheim.
Dr. Irl B. Hirsch reports that he is a consultant for Abbott Diabetes Care, Roche, Intarcia, and Valeritas.
Dr. Samuel Dagogo-Jack reports that he is a consultant for Merck, Novo Nordisk, Janssen, and Boehringer Ingelheim. He has received research grants from Amgen. Additionally, AstraZeneca, Novo Nordisk, and Boehringer Ingelheim have clinical trial contracts with the University of Tennessee for studies in which Dr. Dagogo-Jack serves as the Principal Investigator or Co-Investigator.
Dr. Paul S. Jellinger reports that he has received speaker honoraria from BI-Lilly, AstraZeneca, Novo Nordisk, Merck, and Amgen.
Dr. Ralph Anthony DeFronzo reports that he is on the Advisory Board for AstraZeneca, Novo Nordisk, Janssen, Boehringer Ingelheim, Intarcia, and Ecelyx. He is also a speaker for Novo Nordisk and AstraZeneca. Dr. DeFronzo has received research grant support from Boehringer Ingelheim, Takeda, Janssen, and AstraZeneca.
Dr. Janet B. McGill reports that she is a consultant for Boehringer Ingelheim, Janssen, merck, Novo Nordisk, Calibra, Dynavax, Valertias, and Intarcia. She is also a speaker for Janssen. Dr. McGill has received research grant support from Novartis, Dexcom, Bristol Myers Squibb, and Lexicon.
Dr. Daniel Einhorn reports that he is a consultant for Eli Lilly, Takeda, Novo Nordisk, Adocia, Sanofi, Epitracker, Janssen, Intarcia, Glysens, and Freedom-Meditech and has received research grant support from Novo Nordisk, Eli Lilly, AstraZeneca, Eisai, Janssen, and Sanofi. He is also a shareholder of Halozyme.
Dr. Paul D. Rosenblit reports that he is a consultant for AstraZeneca and a speaker for AstraZeneca (Bristol Myers Squibb), Boehringer Ingelheim, GlaxoSmithKline, Janssen, Merck, Novo Nordisk, and Takeda. He has also received research grant support from Amgen, AstraZeneca, Boehringer Ingelheim, Bristol Myers Squibb, GlaxoSmithKline, Ionis, Eli Lilly, Lexicon, Merck, Novo Nordisk, Orexigen, Pfizer, and Sanofi.
Dr. Vivian A. Fonseca reports that he is a consul- tant for Takeda, Novo Nordisk, Sanofi, Eli Lily, Pamlabs, AstraZeneca, Abbott, Boehringer Ingelheim, Janssen and Intarcia. He is a speaker for Takeda, AstraZeneca, and Sanofi. Dr. Fonseca has also received research grants from Novo Nordisk, Asahi, Eli Lilly, Abbott, Endo Barrier, Bayer, and Gilead.
Dr. Guillermo E. Umpierrez reports that he is a consultant for Sano and Glytec. He also received research grant support from Merck, Sanofi, Boehringer Ingelheim, AstraZeneca, and Novo Nordisk.
Dr. Jeffrey I. Mechanick reports that he is a consultant for Abbott Nutrition International.
Dr. Stephanie Adams reports that she does not have any relevant financial relationships with any commercial interests.
originally posted by: Metallicus
a reply to: M4ngo
So, what exactly are people that need Metformin to keep their sugar under control supposed to do exactly? I find this concerning because I know diabetics and they can't go without this medication.
originally posted by: TiredofControlFreaks
a reply to: Anathros
There are strong proponents for every diet under the sun.
Thanks for restricting me to a high protein diet with little or no carbs. It may work very very well for you but I find it too restrictive to manage for a lifetime. The best I can do is three months. Then I re-introduced a small amount of carbs in my diet and within a month I had regained all the weight I lost.
You can have a weak moment and indulge in carbs once in a while but I can't. The diet of a diabetic has to be something they can live with for the rest of their lives.
I find it easier to eat some carbs but restrict them to a degree.
Its all a matter of personal choice.it
originally posted by: Cauliflower
a reply to: Anathros
If you are type 1 and or taking insulin you may get too many hypoglycemia crashes to stick with keto.
Passing out and hitting your head on the concrete isn't very healthy either.
On the other hand type 2 borderline responds well to targeted ketogenic diets.
originally posted by: TiredofControlFreaks
a reply to: M4ngo
It is definitively ok to disagree M4ngo.
I know that you recommend insulin because it is natural to the body. I went the whole "insulin is natural" fad about 5 years ago.
Unfortunately, insulin, even the powder form that is inhalable does cause weigh gain and has some pretty severe pneumo-pulmonary effects as well.
www.rxlist.com...
If I have to take insulin, I would stick with injectables but yes, something you don't have to inject would be an improvement. We are just not there yet.
One thing is for sure. I am not giving up metformin because of some bogus study on environmental concerns. I have the right to survive just like the minnows do. Metformin may be a neurotoxin and it may kill me at some point in the future but it has kept me alive (without amputations, kidney problems or blindness or diabetic neuropathy) for 30 years now. I am good with delaying death as long as possible
Please remember what I said, its very very important to remember:
50 % of all medical studies cannot be replicated.
That means the study was bogus in the first place.